Analyzing the genetic composition of samples from Thailand, researchers have discovered novel coronavirus subvariants.
The BF.7, BN.1, and BA.2.75.2 coronavirus subvariants were discovered by the Center for Medical Genomics at Ramathibodi Hospital.
The center identified three instances of BA.2.75.2 using genomic monitoring, in addition to two cases of BF.7 and one case of BN.1. These three strains, together with BQ.1.1, BF.7, 2.3.30, BA.2.75.2, BN.1, and XBB, make form a legitimate subvariant of the Omicron family.
The institute reports that between two hundred and two thousand examples of each of these variations have been entered into the GISAID database. Experts predict that by the end of the year or the beginning of next year, strains belonging to this subgroup will replace the BA.5 subvariant as the most common form of the virus worldwide.
Scientists believe that BF.7 or the BA.5.2.1.7 subvariant, because to their enhanced capacity to evade protection from vaccinations and past infections as well as antibody therapies, will emerge as the next dominant strain. There have been confirmed occurrences of this subvariant in North America, Europe, and Asia, including two in Thailand.